{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"41.1","value":"69.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Combination Treatment Group C: INCB053914 80 mg BID + Ruxolitinib","id":"OG000","title":"Parts 3 & 4: INB053914 80 mg BID + Ruxolitinib"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Regimen 2 Week 4","title":"Pharmacokinetics: Cl/F of Combination Treatment Group C INCB053914 80 mg + Ruxolitinib","type":"SECONDARY","unitOfMeasure":"L/h"}